Alpha Tau to Participate in December Investor Conferences
Rhea-AI Summary
Alpha Tau (NASDAQ: DRTS, DRTSW) announced that CFO Raphi Levy will present at two investor conferences in December 2025: a Fireside Chat at the 37th Annual Piper Sandler Healthcare Conference on Dec 3, 2025, 1:00–1:25 PM ET in New York, and a Company Presentation at Sidoti's Year End Virtual Investor Conference on Dec 10, 2025, 11:30 AM–12:00 PM ET.
Mr. Levy will be available for 1x1 investor meetings at both events; investors should contact their Piper Sandler or Sidoti representatives to schedule.
Positive
- None.
Negative
- None.
Details
News Market Reaction – DRTS
On Dec 1, the day this news came out, DRTS closed 4.79% below the previous close.
Data tracked by StockTitan Argus for the Dec 1 session.
Key Figures
- Share price
- $4.96
- Pre-news price on day of article
- Market cap
- $431,436,579
- Pre-news valuation for DRTS
- Cash & deposits
- $75.9M
- As of Q3 2025 per Nov 20, 2025 update
- Net loss (9M)
- $30.5M
- Nine-month 2025 net loss vs prior year
- R&D spend
- $22.5M
- Nine-month 2025 research and development expense
- Manufacturing capacity
- 400,000 sources
- Initial nameplate capacity at New Hampshire facility
- Conference date
- December 3, 2025
- Piper Sandler Healthcare Conference fireside chat
- Conference date
- December 10, 2025
- Sidoti Year End Virtual Investor Conference presentation
Historical Context
-
First GBM patient treated in U.S. pilot study with Alpha DaRT.
-
Two Alpha DaRT pancreatic cancer abstracts accepted for 2026 ASCO GI.
-
FDA IDE approval to start pilot study in locally recurrent prostate cancer.
-
Announcement of December investor conference presentations and 1x1 meetings.
-
Q3 update with higher R&D, increased net loss, and strengthened cash resources.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
alpha-radiation medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
JERUSALEM, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will present in the following investor conferences in December 2025.
| Event: | 37th Annual Piper Sandler Healthcare Conference |
| Format: | Fireside Chat |
| Date: | December 3, 2025 |
| Time: | 1:00 – 1:25PM ET |
| Location: | New York, NY |
| Event: | Sidoti's Year End Virtual Investor Conference |
| Format: | Company Presentation |
| Date: | December 10, 2025 |
| Time: | 11:30AM – 12:00PM ET |
| Location: | Virtual |
Mr. Levy will be available for 1x1 investor meetings at both conferences. Please reach out to your Piper Sandler and Sidoti representatives to schedule.
About Alpha Tau Medical Ltd.
Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.
About Alpha DaRT®
Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is designed to enable highly potent and conformal alpha-irradiation of solid tumors by intratumoral delivery of radium-224 impregnated sources. When the radium decays, its short-lived daughters are released from the sources and disperse while emitting high-energy alpha particles with the goal of destroying the tumor. Since the alpha-emitting atoms diffuse only a short distance, Alpha DaRT aims to mainly affect the tumor, and to spare the healthy tissue around it.
Investor Relations Contact:
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.